{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T11:10:05Z","timestamp":1759057805079,"version":"3.44.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jviromet.2021.114117","type":"journal-article","created":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T09:49:07Z","timestamp":1614505747000},"page":"114117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Generation of an HBV core phenotyping assay for evaluating HBV capsid compounds"],"prefix":"10.1016","volume":"292","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8095-2009","authenticated-orcid":false,"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5428-3494","authenticated-orcid":false,"given":"David","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3856-0815","authenticated-orcid":false,"given":"Dara","family":"Burdette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2105-4748","authenticated-orcid":false,"given":"Ross","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5639-506X","authenticated-orcid":false,"given":"Becket","family":"Feierbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2021.114117_bib0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.antiviral.2017.06.016","article-title":"Antiviral profiling of the capsid assembly modulator BAY41-4109 on full-length HBV genotype A-H clinical isolates and core site-directed mutants in vitro","volume":"144","author":"Berke","year":"2017","journal-title":"Antiviral Res."},{"issue":"8","key":"10.1016\/j.jviromet.2021.114117_bib0010","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1021\/bi801814y","article-title":"A mutant hepatitis B virus core protein mimics inhibitors of icosahedral capsid self-assembly","volume":"48","author":"Bourne","year":"2009","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.jviromet.2021.114117_bib0015","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1128\/AAC.00473-12","article-title":"Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation","volume":"56","author":"Cai","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5608","key":"10.1016\/j.jviromet.2021.114117_bib0020","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.1077215","article-title":"Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids","volume":"299","author":"Deres","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2021.114117_bib0025","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0168-8278(17)30317-3","article-title":"Multiple dose study of GLS4JHS, interfering with the assembly of hepatitis B virus core particles, in patients infected with hepatitis B virus [Abstract PS-046]","volume":"66","author":"Ding","year":"2017","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.jviromet.2021.114117_bib0030","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.12.028","article-title":"Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B","volume":"146","author":"Fung","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jviromet.2021.114117_bib0035","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/S0168-8278(18)30422-7","article-title":"RO7049389, a core protein allosteric modulator, demonstrates robust anti-HBVactivity in chronic hepatitis B patients and is safe and well tolerated [Abstract LBO-003]","volume":"68","author":"Gane","year":"2018","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.jviromet.2021.114117_bib0040","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1128\/AAC.42.12.3179","article-title":"Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2\u2019,3\u2019-dideoxy-3\u2019-thiacytidine","volume":"42","author":"King","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"49","key":"10.1016\/j.jviromet.2021.114117_bib0045","doi-asserted-by":"crossref","first-page":"15196","DOI":"10.1073\/pnas.1513803112","article-title":"High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein","volume":"112","author":"Klumpp","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.jviromet.2021.114117_bib0050","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01734-18","article-title":"Preclinical characterization of NVR 3-778, a first-in-Class capsid assembly modulator against hepatitis B virus","volume":"63","author":"Lam","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2021.114117_bib0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.antiviral.2016.12.012","article-title":"Tenofovir alafenamide demonstrates broad cross-genotype activity against wild-type HBV clinical isolates and maintains susceptibility to drug-resistant HBV isolates in vitro","volume":"139","author":"Liu","year":"2017","journal-title":"Antiviral Res."},{"issue":"23","key":"10.1016\/j.jviromet.2021.114117_bib0060","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa0802878","article-title":"Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B","volume":"359","author":"Marcellin","year":"2008","journal-title":"N. Engl. J. Med."},{"article-title":"Evidence for ongoing Low-level viremia in patients with chronic hepatitis B receiving long-term nucleos(t)ide analog therapy [Poster 1861]","year":"2014","series-title":"The 65th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting (AASLD)","key":"10.1016\/j.jviromet.2021.114117_bib0065"},{"key":"10.1016\/j.jviromet.2021.114117_bib0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cbpa.2019.02.009","article-title":"Recent advances in the development of HBV capsid assembly modulators","volume":"50","author":"Nijampatnam","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"6","key":"10.1016\/j.jviromet.2021.114117_bib0075","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1097-2765(01)80009-5","article-title":"The crystal structure of the human hepatitis B virus capsid","volume":"3","author":"Wynne","year":"1999","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.jviromet.2021.114117_bib0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2003.07.003","article-title":"In vitro antiviral susceptibility of full-length clinical hepatitis B virus isolates cloned with a novel expression vector","volume":"61","author":"Yang","year":"2004","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jviromet.2021.114117_bib0085","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/acsinfecdis.8b00337","article-title":"Treatment of chronic hepatitis B virus infection using small molecule modulators of nucleocapsid assembly: recent advances and perspectives","volume":"5","author":"Yang","year":"2019","journal-title":"ACS Infect. Dis."},{"article-title":"Final Results of a Phase 1b 28-Day Study of ABI-H0731, a Novel Core Inhibitor, in Non-Cirrhotic Viremic Subjects with Chronic Hepatitis B [Abstract 73]","year":"2018","series-title":"AASLD: The Liver Meeting\u00ae","key":"10.1016\/j.jviromet.2021.114117_bib0090"},{"issue":"5","key":"10.1016\/j.jviromet.2021.114117_bib0095","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1053\/j.gastro.2018.12.023","article-title":"Antiviral activity, safety, and pharmacokinetics of capsid assembly modulator NVR 3-778 in patients with chronic HBV infection","volume":"156","author":"Yuen","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jviromet.2021.114117_bib0100","first-page":"1","article-title":"Heteroaryldihydropyrimidine (HAP) and sulfamoylbenzamide (SBA) inhibit hepatitis B virus replication by different molecular mechanisms","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jviromet.2021.114117_bib0105","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jviromet.2011.03.006","article-title":"HBV DNA replication mediated by cloned patient HBV reverse transcriptase genes from HBV genotypes A-H and its use in antiviral phenotyping assays","volume":"173","author":"Zhu","year":"2011","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2021.114117_bib0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2015.06.020","article-title":"Core protein: a pleiotropic keystone in the HBV lifecycle","volume":"121","author":"Zlotnick","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jviromet.2021.114117_bib0115","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.04.036","article-title":"JNJ-56136379, an HBV capsid assembly modulator, is well-tolerated and has antiviral activity in a phase 1 study of patients with chronic infection [Journal Pre-Proof]","author":"Zoulim","year":"2020","journal-title":"Gastroenterology"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093421000562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093421000562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:53:28Z","timestamp":1759056808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093421000562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":23,"alternative-id":["S0166093421000562"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2021.114117","relation":{},"ISSN":["0166-0934"],"issn-type":[{"type":"print","value":"0166-0934"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of an HBV core phenotyping assay for evaluating HBV capsid compounds","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2021.114117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114117"}}